Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Insulin receptor | ||
Ligand | BDBM50315887 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2264501 | ||
IC50 | 75±n/a nM | ||
Citation | Turvey, SJ; McPhillie, MJ; Kearney, MT; Muench, SP; Simmons, KJ; Fishwick, CWG Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR-IGF1R hybrid receptor modulators. RSC Med Chem13:360-374 (2022) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Insulin receptor | |||
Name: | Insulin receptor | ||
Synonyms: | INSR | INSR protein | INSR_HUMAN | Insulin receptor (IR) | Insulin receptor beta subunit | ||
Type: | Receptor Tyrosine Kinase | ||
Mol. Mass.: | 156322.60 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P06213 | ||
Residue: | 1382 | ||
Sequence: |
| ||
BDBM50315887 | |||
n/a | |||
Name | BDBM50315887 | ||
Synonyms: | (1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol | CHEMBL1091644 | OSI-906 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H23N5O | ||
Mol. Mass. | 421.4937 | ||
SMILES | C[C@@]1(O)C[C@@H](C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12 |r,wU:1.1,4.6,wD:1.0,(18.42,-37.26,;17.1,-36.49,;16.31,-37.82,;17.79,-35.11,;16.41,-34.42,;15.72,-35.8,;15.93,-32.97,;16.83,-31.71,;15.91,-30.47,;16.38,-29.01,;15.35,-27.88,;15.81,-26.41,;17.32,-26.08,;17.78,-24.62,;19.27,-24.29,;20.31,-25.42,;19.85,-26.89,;18.35,-27.21,;17.89,-28.68,;21.81,-25.09,;22.85,-26.23,;24.35,-25.9,;24.82,-24.43,;23.77,-23.29,;22.27,-23.63,;14.45,-30.96,;13.11,-30.19,;13.11,-28.65,;11.78,-30.96,;11.78,-32.51,;13.12,-33.28,;14.46,-32.5,)| | ||
Structure |